Corundum Open Innovation
Overview
Corundum Open Innovation is an Israel-Japan venture capital firm, backed by Japanese corporations, investing in top Israeli high-tech companies and top Israeli funds . With teams in both Japan and Israel, Corundum provides access to the Israeli High-Tech Eco System and hands-on business development for investors and portfolio companies .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Appcharge | Aug 2025 | Series B | Co-investor |
| Theranica | Aug 2022 | Series C | Co-investor |
| Embr Labs | Dec 2020 | Early Funding | - |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Corundum Open Innovation based?
Headquarters information for Corundum Open Innovation is not publicly available.
When was Corundum Open Innovation founded?
Corundum Open Innovation was founded in 2015.
How many portfolio companies does Corundum Open Innovation have?
Corundum Open Innovation has 4 portfolio companies in Caplight's dataset.
What are some companies in Corundum Open Innovation's portfolio?
Portfolio companies visible on Caplight include Appcharge, Theranica, Embr Labs.
What was Corundum Open Innovation's most recent investment shown here?
Corundum Open Innovation's most recent investment in this portfolio sample was in Appcharge in 2025.
What sectors does Corundum Open Innovation focus on?
Corundum Open Innovation focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Media, Entertainment & Gaming, Consumer & Commerce, FinTech.
What company stages does Corundum Open Innovation focus on?
Corundum Open Innovation typically invests at the Mid stage.
What is Corundum Open Innovation's AUM?
Corundum Open Innovation's assets under management are estimated between $0.0 and $50.0M.